DE3888205D1 - Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. - Google Patents

Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.

Info

Publication number
DE3888205D1
DE3888205D1 DE88906809T DE3888205T DE3888205D1 DE 3888205 D1 DE3888205 D1 DE 3888205D1 DE 88906809 T DE88906809 T DE 88906809T DE 3888205 T DE3888205 T DE 3888205T DE 3888205 D1 DE3888205 D1 DE 3888205D1
Authority
DE
Germany
Prior art keywords
treating lung
preparations therefor
affects
lung affects
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88906809T
Other languages
English (en)
Other versions
DE3888205T2 (de
Inventor
Arthur Ammann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE3888205D1 publication Critical patent/DE3888205D1/de
Application granted granted Critical
Publication of DE3888205T2 publication Critical patent/DE3888205T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3888205T 1987-08-07 1988-07-29 Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. Expired - Lifetime DE3888205T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/083,605 US4944941A (en) 1987-08-07 1987-08-07 Methods and compositions for the treatment of lung conditions
PCT/US1988/002609 WO1989001341A1 (en) 1987-08-07 1988-07-29 Methods and compositions for the treatment of lung conditions

Publications (2)

Publication Number Publication Date
DE3888205D1 true DE3888205D1 (de) 1994-04-07
DE3888205T2 DE3888205T2 (de) 1994-08-11

Family

ID=22179461

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3888205T Expired - Lifetime DE3888205T2 (de) 1987-08-07 1988-07-29 Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.

Country Status (8)

Country Link
US (1) US4944941A (de)
EP (1) EP0395639B1 (de)
JP (1) JP2765585B2 (de)
AU (1) AU2260088A (de)
CA (1) CA1335175C (de)
DE (1) DE3888205T2 (de)
NZ (1) NZ225675A (de)
WO (1) WO1989001341A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
IT1248838B (it) * 1990-06-13 1995-01-30 Sclavo Spa Soluzioni tampone contenenti collagenasi, loro preparazione ed uso perla diluizione di sieri umani
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5204094A (en) * 1991-01-17 1993-04-20 Roussel Uclaf Treatment of pneumothorax
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
US5266312A (en) * 1992-01-07 1993-11-30 National Jewis Center For Immunology And Respiratory Medicine Method for treating a steroid resistant condition via administration of gamma interferon
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5248504A (en) * 1992-03-02 1993-09-28 Friedman William H Method of treatment for nasal and sinus dysfunction
US5582825A (en) * 1993-02-24 1996-12-10 Gunze Limited Therapeutic medicine for cystic fibrosis
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US5830436A (en) * 1993-03-30 1998-11-03 Duke University Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
US5840277A (en) * 1993-03-30 1998-11-24 Charlotte Hospital Authority Treatment of chronic pulmonary inflammation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
CA2200879A1 (en) * 1995-07-25 1997-02-13 Nobutaka Ida Drug for treating bone disorders
EP0795332B1 (de) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Medizinische Verwendung von Gamma-Interferon im interstitiellen Lungenerkrankungen
ATE410181T1 (de) 1998-04-02 2008-10-15 Genentech Inc Verwendung von intereferon gamma zur behandlung von herzhypertrophie
US6858223B2 (en) * 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
HUP0203409A3 (en) * 1999-11-12 2005-06-28 Maxygen Holdings Ltd Redwood C Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
EP1351707B9 (de) * 2001-01-09 2012-01-25 Baylor Research Institute Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
CA2491178A1 (en) * 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
ES2339954T3 (es) * 2004-08-06 2010-05-27 Nycomed Gmbh Composicion que comprende un agente tensioactivo pulmonar y un peptido derivado de tnf.
WO2006093153A1 (ja) 2005-02-28 2006-09-08 Cellseed Inc. 培養細胞シート、製造方法及びその利用した組織修復方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
ES2032831T5 (es) * 1986-08-19 2001-02-16 Genentech Inc Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
EP0271447B1 (de) * 1986-12-12 1993-03-10 Ciba-Geigy Ag Vorbeugende Massnahmen zur Verhinderung der "Komplexen Respiratorischen Erkrankung bei Rindern" durch Verabreichung von Interferon

Also Published As

Publication number Publication date
JP2765585B2 (ja) 1998-06-18
EP0395639B1 (de) 1994-03-02
EP0395639A1 (de) 1990-11-07
CA1335175C (en) 1995-04-11
US4944941A (en) 1990-07-31
DE3888205T2 (de) 1994-08-11
NZ225675A (en) 1991-02-26
WO1989001341A1 (en) 1989-02-23
AU2260088A (en) 1989-03-09
JPH03500768A (ja) 1991-02-21

Similar Documents

Publication Publication Date Title
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE3877834D1 (de) Verfahren zur behandlung von abgasen.
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE3583942D1 (de) Verfahren zur behandlung von fluiden.
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE3852912D1 (de) Verfahren und Gerät zur Kathodenzerstäubung.
DE3782801D1 (de) Verfahren zur schlagfeld-freund-feind-kennung und system zum ausfuehren davon.
DE3856398D1 (de) Verfahren zur Behandlung von Gleitkörpern
DE3860919D1 (de) Verbesserte detergens-bleichmittelzusammensetzung und verfahren zur reinigung von geweben.
DE3781535D1 (de) Verfahren und vorrichtung zur aseptischen behandlung von lebensmitteln.
DE3789887D1 (de) Verfahren und Apparat zur Prüfung von Gesamtblut.
DE3873094D1 (de) Verfahren zur aufbereitung von gas.
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DE3668473D1 (de) Verfahren zur behandlung von oberflaechen und apparatur dafuer.
DE3668172D1 (de) Verfahren zur behandlung von aktiviertem siliciumpulver.
DE3670145D1 (de) Verfahren zur behandlung von abfall.
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.
DE3765137D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE3578161D1 (de) Verfahren zur behandlung von fluessigkeiten.
DE3886755D1 (de) Verfahren zur behandlung von gefässkrankheiten.
DE3873846D1 (de) Behandlungsapparat und verfahren.
DE3781279D1 (de) Verfahren zur behandlung von blut.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition